SEC Filings

10-Q
MEDTRONIC PLC filed this Form 10-Q on 12/04/2017
Entire Document
 


Medtronic plc
Consolidated Balance Sheets
(Unaudited)
(in millions)
October 27, 2017
 
April 28, 2017
ASSETS
 

 
 

 
 
 
 
Current assets:
 

 
 

Cash and cash equivalents
$
5,529

 
$
4,967

Investments
7,997

 
8,741

Accounts receivable, less allowances of $168 and $155, respectively
5,752

 
5,591

Inventories, net
3,638

 
3,338

Other current assets
2,246

 
1,865

Current assets held for sale

 
371

Total current assets
25,162

 
24,873

 
 
 
 
Property, plant, and equipment
10,115

 
9,691

Accumulated depreciation
(5,674
)
 
(5,330
)
Property, plant, and equipment, net
4,441

 
4,361

Goodwill
39,077

 
38,515

Other intangible assets, net
22,625

 
23,407

Tax assets
1,749

 
1,509

Other assets
1,404

 
1,232

Noncurrent assets held for sale

 
5,919

Total assets
$
94,458

 
$
99,816

 
 
 
 
LIABILITIES AND EQUITY
 

 
 

 
 
 
 
Current liabilities:
 

 
 

Current debt obligations
$
3,131

 
$
7,520

Accounts payable
1,718

 
1,731

Accrued compensation
1,502

 
1,860

Accrued income taxes
872

 
633

Other accrued expenses
3,273

 
2,442

Current liabilities held for sale

 
34

Total current liabilities
10,496

 
14,220

 
 
 
 
Long-term debt
25,941

 
25,921

Accrued compensation and retirement benefits
1,475

 
1,641

Accrued income taxes
2,194

 
2,405

Deferred tax liabilities
1,841

 
2,978

Other liabilities
933

 
1,515

Noncurrent liabilities held for sale

 
720

Total liabilities
42,880

 
49,400

 
 
 
 
Commitments and contingencies (Note 17)

 

 
 
 
 
Shareholders’ equity:
 

 
 

Ordinary shares— par value $0.0001, 2.6 billion shares authorized, 1,353,591,988 and 1,369,424,818 shares issued and outstanding, respectively

 

Additional paid-in capital
28,091

 
29,551

Retained earnings
25,438

 
23,356

Accumulated other comprehensive loss
(2,060
)
 
(2,613
)
Total shareholders’ equity
51,469

 
50,294

Noncontrolling interests
109

 
122

Total equity
51,578

 
50,416

Total liabilities and equity
$
94,458

 
$
99,816

The accompanying notes are an integral part of these consolidated financial statements.

3

X